Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients.

Trial Profile

Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Valganciclovir (Primary) ; Ganciclovir
  • Indications Cytomegalovirus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 May 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 12 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top